Neurotech Pharmaceuticals, INC
Doing business as Neurotech USA CORP
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCumberland, RI
US patents9
SAM.gov UEISSYBDBA61GV4
CAGE code10UU1
Incorporated inDE
- therapies
- chronic eye diseases
- platform releases Ciliary Neurotrophic Factor
- Type 2
Named on the company’s own website, read JUL 29, 2026
Open positions
Openings read from Neurotech Pharmaceuticals, INC’s own job board on ADP, last checked OCT 27, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Maintenance TechnicianNeurotech Pharmaceuticals, INC · Cumberland, RI, US · posted OCT 9, 2026
- Field Reimbursement DirectorUS · posted SEP 17, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
9 US patents granted 2010–2025, 2 of them in the five years to SEP 2025.
Pharmaceuticals 9
- Use of encapsulated cell therapy for treatment of ophthalmic disordersUS 12,357,566 · granted JUL 15, 2025
- Use of encapsulated cell therapy for treatment of ophthalmic disordersUS 11,207,266 · granted DEC 28, 2021
- Use of encapsulated cell therapy for treatment of ophthalmic disordersUS 10,456,356 · granted OCT 29, 2019
- Use of encapsulated cell therapy for treatment of ophthalmic disordersUS 10,195,140 · granted FEB 5, 2019
- Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereofUS 10,004,804 · granted JUN 26, 2018
Newest 5 shown · Granted to Neurotech USA, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neurotech Pharmaceuticals, INC | Cumberland | RI | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.